Biosimilars

Globalization Of Biosimilars

The primary purpose of biosimilars is to reduce the healthcare costs associated with the use of biologics and thereby increase access to healthcare. Unlike small molecule generics, the bioequivalence approach is not considered appropriate for the approval of biosimilars. Many experts believe that biosimilars are essential to the future of healthcare because they lead to greater competition and innovation in the market, causing prices to drop and allowing greater access to the medication for patients — wherever in the world they may be.